Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trial German regulatory agency, Paul-Ehrlic…
First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trial German regulatory agency, Paul-Ehrlic…
― Acculogic Inc., a global leader in electronic production test solutions, announces that it will exhibit in Booth #1011…
Compelling aesthetics and outstanding efficiency are the hallmarks of the latest model range from premium carmaker BMW.…